Recent Posts

Diverse Stocks in Expert’s Opinion: Hilton Worldwide (NYSE:HLT), Roche Holding Ltd.’s (OTCMKTS:RHHBY)

Roche Holding Ltd.’s  (ADR) (OTCMKTS:RHHBY) unit Genentech reports Phase 3 study for Gazyva shows superior progression-free survival compared to Rituxan-based standard of care treatment (RHHBY). The firm announced data from the positive, pivotal Phase III GALLIUM study that compared Gazyva plus chemotherapy followed by Gazyva alone head-to-head against Rituxan plus …

Read More »